NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/27/2023
Back to search
Official data from USPTO
KENOTA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
KENOTA
ST13
US500000088794131Class
5, 9, 10, 42
Filing
88794131
Registration
7089131
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
59
Latest update
06/27/2023
Trademark type
Word
Nice classes
5, 9, 10, 42
Filing date
02/12/2020
Registration date
06/27/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/27/2023
Last transaction
06/27/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
First use anywhere
01/05/2023
First use in commerce
01/05/2023
Drawing code
4
Owner type
03
Owner location
Kitchener, Ontario, CA
Examiner
DUBOIS, SUSAN L
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Kenota Inc.
Representatives
Erika L. Jenkins, Esq. POMEROY LAW GROUP PLLC
Technical classification
Nice Classes
Class 5Class 9Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Transdermal patches for use in medical diagnostics to treat allergiesinfectious diseasesneurological disorderscardiovascular diseasesskin disorderscancersendocrine disordersto monitor general health biomarkers for medical and veterinary purposes; transdermal patches for use in drug delivery and immunotherapy delivery applications to treat allergiesinfectious diseasesneurological disorderscardiovascular diseasesskin disorderscancersendocrine disordersto monitor general health biomarkers for medical and veterinary purposes; biochemical assays for testing body fluids for use in medical diagnostics and point-of-care diagnostics for medical and veterinary purposes
Class 9
Computer hardware platform for use in medical diagnostics to treat allergiesinfectious diseasesneurological disorderscardiovascular diseasesskin disorderscancersendocrine disordersto monitor general health biomarkers for medical and veterinary purposes
Class 10
Medical equipment in the nature of microfluidic testing systemsblood testing and analysis systemslateral flow assay testing systems for use in medical diagnostics to treat allergiesinfectious diseasesneurological disorderscardiovascular diseasesskin disorderscancersendocrine disordersto monitor general health biomarkers for medical and veterinary purposes; micro needles and finger-prick blood sample collection instruments for medical and veterinary purposes; medical deviceslancetssyringesblood collectorscartridgescartridge sleevesfor medical and veterinary purposes; medical devices for use in microfluidicspaper-based microfluidics and microfluidic chips for medical and veterinary purposes; finger prick needles for medical and veterinary purposes
Class 42
Medical device research and development services for medical and veterinary purposes; research and development services in the area of in vitro diagnostics (IVD) for medical and veterinary purposes; point-of-care medical device research and development services for medical and veterinary purposes; research and development services in the area of allergy testing for medical and veterinary purposes; research and development services in the area of transdermal pharmaceutical drug delivery for medical and veterinary purposes; research and development services in the area of transdermal immunotherapy delivery for medical and veterinary purposes; all of the aforementioned services being performed for others
Publications
History of USPTO decisions and trademark events.
59 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/27/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/11/2023
PUBO
PUBLISHED FOR OPPOSITION
04/11/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/22/2023
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
03/07/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/06/2023
IUAA
USE AMENDMENT ACCEPTED
03/06/2023
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
02/28/2023
IUAF
USE AMENDMENT FILED
02/28/2023
EAAU
TEAS AMENDMENT OF USE RECEIVED
02/27/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/23/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/23/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/22/2023
DOCK
ASSIGNED TO EXAMINER
01/17/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/28/2022
GNSL
LETTER OF SUSPENSION E-MAILED
11/28/2022
CNSL
SUSPENSION LETTER WRITTEN
11/28/2022
DOCK
ASSIGNED TO EXAMINER
10/26/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/25/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/25/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/25/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
10/25/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/18/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/18/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/18/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
08/16/2022
GNSI
INQUIRY TO SUSPENSION E-MAILED
08/16/2022
CNSI
SUSPENSION INQUIRY WRITTEN
08/16/2022
DOCK
ASSIGNED TO EXAMINER
08/12/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
06/29/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
06/10/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/15/2021
GNSL
LETTER OF SUSPENSION E-MAILED
11/15/2021
CNSL
SUSPENSION LETTER WRITTEN
11/15/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/10/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/10/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/10/2021
ALIE
ASSIGNED TO LIE
09/10/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/02/2021
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
08/16/2021
GNSI
INQUIRY TO SUSPENSION E-MAILED
08/16/2021
CNSI
SUSPENSION INQUIRY WRITTEN
08/16/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
08/04/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/04/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/04/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/04/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/28/2020
GNSL
LETTER OF SUSPENSION E-MAILED
10/28/2020
CNSL
SUSPENSION LETTER WRITTEN
10/28/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/08/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/08/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/06/2020
GNRT
NON-FINAL ACTION E-MAILED
05/06/2020
CNRT
NON-FINAL ACTION WRITTEN
05/06/2020
DOCK
ASSIGNED TO EXAMINER
05/02/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/18/2020
NWAP
NEW APPLICATION ENTERED
02/15/2020
Continuous trademark protection
Get notified about every new filing that threatens KENOTA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.